SCHEMBL26553207

SCHEMBL26553207

N#Cc1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c2)cc1-c1ccccc1-c1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 3/20 0.43
▸ CYP11B2 P19099 3/20 0.43
▸ ALDH1A1 P00352 4/20 0.41
▸ LMNA P02545 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ ABCG2 Q9UNQ0 4/20 0.40
▸ GABRG2 P18507 2/20 0.40
▸ GABRB3 P28472 2/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ TRPA1 O75762 1/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ TSHR P16473 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25775148 0.94 CYP11B1 (0.43) CYP11B1CYP11B2ALDH1A1LMNAKDM4E
SCHEMBL26553201 0.93 CYP11B1 (0.42) CYP11B1CYP11B2ALDH1A1LMNAKDM4E
SCHEMBL26581889 0.93 ALDH1A1 (0.46) CYP11B1CYP11B2ALDH1A1LMNAKDM4E
SCHEMBL25774348 0.91 ALDH1A1 (0.43) CYP11B1CYP11B2ALDH1A1LMNAKDM4E
SCHEMBL25775108 0.90 CYP11B1 (0.46) CYP11B1CYP11B2ALDH1A1LMNAKDM4E
SCHEMBL25774347 0.90 CYP11B1 (0.46) CYP11B1CYP11B2ALDH1A1LMNAKDM4E
SCHEMBL25775099 0.90 CYP11B1 (0.46) CYP11B1CYP11B2ALDH1A1LMNAKDM4E
SCHEMBL26553199 0.90 CYP11B1 (0.46) CYP11B1CYP11B2ALDH1A1LMNAKDM4E
SCHEMBL26553184 0.89 ALDH1A1 (0.41) CYP11B1CYP11B2ALDH1A1LMNAKDM4E
SCHEMBL23384199 0.88 GABRG2 (0.44) CYP11B1CYP11B2ALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME NR2E3, NR2E1, NR0B2 CYP11B1 1294/4885CYP11B2 1192/4885ALDH1A1 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback